State of Michigan Retirement System’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
AIM
OAG
GP
SOCM
State of Michigan Retirement System's CRSP Position: Q2 2026 in Review
State of Michigan Retirement System opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 82,547 shares worth $4.5M. The stake represents 0.02% of the portfolio and ranks #481 among its holdings. This is a return to the name: State of Michigan Retirement System previously reported a position in CRSP as recently as Q3 2021.
State of Michigan Retirement System first reported a position in CRSP in Q3 2020 and has held it in 6 quarters since. The position peaked at $5.24M in Q2 2021. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.
- State of Michigan Retirement System held 82,547 shares of CRISPR Therapeutics worth $4.5M as of Q2 2026.
- CRISPR Therapeutics was a new State of Michigan Retirement System position in Q2 2026.
- CRISPR Therapeutics made up 0.02% of State of Michigan Retirement System's portfolio in Q2 2026, its #481 holding.
- State of Michigan Retirement System first reported a position in CRISPR Therapeutics in Q3 2020 and has held it in 6 quarters since.
- State of Michigan Retirement System's CRISPR Therapeutics position peaked at $5.24M in Q2 2021.
- 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.
Based on State of Michigan Retirement System's 13F filing for Q2 2026, filed 30 Jul 2026.